Revere Pharmaceuticals Inc. — Form D

Revere Pharmaceuticals Inc. of ARLINGTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-06-12. The offering totals $3.6M, of which $1.6M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2023-06-12
Form: D
Accession: 0001778959-23-000001
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $3.6M
Amount sold: $1.6M
Remaining: $1.9M
Investors: 22
Date of first sale: 2023-06-01
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-483952

Issuer

Name: Revere Pharmaceuticals Inc.
CIK: 0001778959
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2016
Address: 36 ORVIS ROAD, ARLINGTON, MA, 02474
Phone: 781-718-9033

Officers, directors & promoters (6)

Name	Role	Location
Jedd Robert Levine	Director	Arlington, MA
Marc Robert Lippman	Director	Arlington, MA
Kollol Robert Pal	Director	Arlington, MA
Ian Robert Silverman	Director	Arlington, MA
Jedd Robert Levine	Executive Officer	Arlington, MA
Ian Robert Silverman	Executive Officer	Arlington, MA

Other filings by this issuer (4)

Filed	Form	Offering	Sold
2021-09-01	D	$2.0M	$1.1M
2021-01-12	D/A	$3.5M	$3.5M
2020-06-22	D/A	$3.5M	$1.6M
2019-06-21	D	$1.9M	$1.2M

More